A Phase I/II, Multicenter, Randomized Dose-Escalation Study of Oral AEE788 on Intermittent Dosing Schedules in Adult Patients With Advanced Cancer (Effective Amendment 5) Previously Entitled A Phase IA, Multicenter, Dose-Escalating Study of Oral AEE788 on a Continuous Daily Dosing Schedule in Adult Patients With Advanced Cancer.
Phase of Trial: Phase I
Latest Information Update: 06 Jan 2012
At a glance
- Drugs AEE 788 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 29 Sep 2008 Status changed from active, no longer recruiting to completed.
- 23 Jan 2008 Status changed from recruiting to in progress.
- 13 Nov 2005 New trial record.